FDA Approved: * August 9, 2021
Pharm Company: * CIPLA
Category: Vision / Eye Health

Difluprednate is a corticosteroid, It is chemically a butyrate ester of 6(alpha),9(alpha)-difluoro prednisolone acetate. Accordingly, difluprednate is sometimes abbreviated DFBA, for difluoroprednisolone butyrate acetate. Approval On June 24, 2008, the US Food and Drug Administration (FDA) approved difluprednate for the treatment of post-operative ocular inflammation and pain.[1] It is marketed by Alcon under the tradename Durezol. Clinical trials Difluprednate ophthalmi... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Difluprednate Ophthalmic Emulsion Ophthalmic Emulsion .5 mg/ml Ophthalmic Emulsion
NDC: 43598-588
Dr. Reddy's Laboratories Inc.
Difluprednate .5 mg/ml Ophthalmic Emulsion
NDC: 69097-341
Cipla USA Inc.
Difluprednate .5 mg/ml Ophthalmic Emulsion
NDC: 69238-1380
Amneal Pharmaceuticals Ny LLC
Difluprednate .5 mg/ml Ophthalmic Emulsion
NDC: 76282-708
Exelan Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients